Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Ratings for FMC (NYSE:FMC) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 5 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 3 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $65.33, a high estimate of $79.00, and a low estimate of $59.00. Surpassing the previous average price target of $64.20, the current average has increased by 1.76%.
The standing of FMC among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Jeffrey Zekauskas | JP Morgan | Raises | Neutral | $59.00 | $50.00 |
Benjamin Theurer | Barclays | Raises | Equal-Weight | $65.00 | $62.00 |
Joel Jackson | BMO Capital | Raises | Market Perform | $65.00 | $60.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $79.00 | $81.00 |
Richard Garchitorena | Wells Fargo | Lowers | Equal-Weight | $62.00 | $68.00 |
Benjamin Theurer | Barclays | Announces | Equal-Weight | $62.00 | - |
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of FMC's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on FMC analyst ratings.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining FMC's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.36% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: FMC's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 28.33%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.63%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): FMC's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.44%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 0.92, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: FMC